ClassID:

20931

A61K38/1751 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals Bactericidal/permeability-increasing protein [BPI]

Recent Application in this class:
#1
20210128681
2021-05-06

Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein

#2
20190224362
2019-07-25

Antimicrobial biopolymer compositions, methods of synthesis, and applications of use

#3
20180355005
2018-12-13

Bacteriocidal peptides and uses thereof

#4
20170354712
2017-12-14

BPI AND ITS CONGENERS AS RADIATION MITIGATORS AND RADIATION PROTECTORS

#5
20170281727
2017-10-05

THERAPEUTIC OR PROPHYLACTIC AGENT FOR ITCHING SKIN DISEASES

#6
20170065676
2017-03-09

BPI and its congeners as radiation mitigators and radiation protectors

#7
20170056471
2017-03-02

BPI and its congeners as radiation mitigators and radiation protectors

#8
20150209405
2015-07-30

Antibacterial composition for topical use

#9
20140142024
2014-05-22

BPI and its congeners as radiation mitigators and radiation protectors

#10
20120014979
2012-01-19

USE OF BCL6 INHIBITORS FOR TREATING AUTOIMMUNE DISEASES

#11
20110144002
2011-06-16

Use of AMPs for treatment of UTI/cystitis

#12
20100056431
2010-03-04

MEDICAL USES

#13
20080119410
2008-05-22

Modulation of Pericyte Proliferation

#14
20080107717
2008-05-08

METHODS AND MATERIALS INCLUDING TREATING ACNE RELATED APPLICATIONS

#15
20070185022
2007-08-09

Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products

#16
20060252688
2006-11-09

Therapeutic uses of BPI protein products in BPI-deficient humans

#17
20060171937
2006-08-03

Method of treating chronic cardiac disease

#18
20050153889
2005-07-14

Modulation of pericyte proliferation

#19
20050148495
2005-07-07

Methods and materials including for treating acne

#20
20050118112
2005-06-02

Treatment of Mycobacterial diseases by administration of bacterial/permeability-increasing protein products

#21
20050080008
2005-04-14

Antithrombotic materials and methods